US 7704509
Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
granted A61KA61K2039/525A61P
Quick answer
US patent 7704509 (Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens) held by The United States of America expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America
- Grant date
- Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 270
- CPC classes
- A61K, A61K2039/525, A61P, A61P31/14